General Statement of Knowledge Ecology International – Sixty-First Series of Meetings of the Assemblies of the Member States of WIPO (WIPO Assemblies)

General Statement of Knowledge Ecology International – Sixty-First Series of Meetings of the Assemblies of the Member States of WIPO (WIPO Assemblies) Agenda item 5 – General Statements 21 September 2020 In relation to the COVID-19 response, Knowledge Ecology International… Continue Reading

WIPO Side event: Appraising Progress of WHO’s COVID-19 Technology Access Pool (C-TAP)

DATE: Tuesday, 22 September 2020 TIME: 18:00 CEST to 19:00 CEST CONVENER: Knowledge Ecology International (KEI) REGISTRATION: Please contact thiru [at] keionline.org On occasion of the 61st Series of Meetings of the WIPO General Assembly, Knowledge Ecology International (KEI) is… Continue Reading

Joint letter to WHO formally requesting the R&D Observatory to play a more relevant role in the COVID-19 response

On Friday, 28 August 2020, six groups including Corporación Innovarte, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos wrote a joint letter to the World Health Organization’s (WHO) Chief Scientist, Dr. Soumya Swaminathan,… Continue Reading

Moderna

KEI Reports and Posts 2020. October 8. KEI on Moderna’s Oct 8, 2020 Statement on Intellectual Property Matters during the COVID-19 Pandemic. https://www.keionline.org/34112 2020. September 18. DARPA letter to KEI confirming investigation of Moderna for failure to report government funding… Continue Reading

WTO TRIPS Council (July 2020): The European Union’s position on the interface of IP and health technologies in the COVID-19 response

On 30 July 2020, the World Trade Organization (WTO) convened a formal meeting of the TRIPS Council. The TRIPS Council held discussions on two COVID-19 related topics: agenda item 3 on IP Measures in the Context of COVID-19 and agenda… Continue Reading

Joint letter to Dr. Fauci at NIAID, regarding the geographic scope of RNAceuticals HIV patent license, asks that exclusivity not extend to countries with low and moderate incomes

Below is a letter from several individuals and groups, asking that NIAID not grant exclusive rights in a HIV patent license for South Africa, India and other low income countries. (PDF version here) The license is to RNAceuticals, a firm… Continue Reading

WTO TRIPS Council (July 2020): South Africa’s submission on IP and the Public Interest – Beyond Access to Medicines and Medical Technologies towards a more Holistic Approach to TRIPS Flexibilities

On Friday, 17 July 2020, South Africa submitted a paper to the World Trade Organization (WTO) TRIPS Council entitled, Intellectual Property and the Public Interest: Beyond Access to Medicines and Medical Technologies Towards a More Holistic Approach To TRIPS Flexibilities.… Continue Reading